Clinical Trial Update: A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation [Phase 2]

View source ↗

Summary

Phase 2 dose‑response study evaluating the efficacy and safety of ASP0456 in chronic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• ASP0456

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Constipation | Phase 2 | Status: COMPLETED